UA104684C2 - Промежуточное соединение для получения агомелатина (варианты) и способ его получения (варианты) - Google Patents
Промежуточное соединение для получения агомелатина (варианты) и способ его получения (варианты)Info
- Publication number
- UA104684C2 UA104684C2 UAA201300117A UAA201300117A UA104684C2 UA 104684 C2 UA104684 C2 UA 104684C2 UA A201300117 A UAA201300117 A UA A201300117A UA A201300117 A UAA201300117 A UA A201300117A UA 104684 C2 UA104684 C2 UA 104684C2
- Authority
- UA
- Ukraine
- Prior art keywords
- agomelatine
- intermediates
- preparation
- present
- new intermediates
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 11
- 229960002629 agomelatine Drugs 0.000 title abstract 8
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 title abstract 7
- 238000002360 preparation method Methods 0.000 title abstract 7
- 238000000034 method Methods 0.000 abstract 4
- 238000006243 chemical reaction Methods 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- GABLTKRIYDNDIN-UHFFFAOYSA-N 7-methoxy-3,4-dihydro-2h-naphthalen-1-one Chemical compound C1CCC(=O)C2=CC(OC)=CC=C21 GABLTKRIYDNDIN-UHFFFAOYSA-N 0.000 abstract 1
- 229940126062 Compound A Drugs 0.000 abstract 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 238000004440 column chromatography Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Battery Electrode And Active Subsutance (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101973700A CN102276492B (zh) | 2010-06-08 | 2010-06-08 | 阿戈美拉汀中间体及其制备方法 |
PCT/CN2011/075438 WO2011153939A1 (en) | 2010-06-08 | 2011-06-08 | Agomelatine intermediates and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
UA104684C2 true UA104684C2 (ru) | 2014-02-25 |
Family
ID=45097542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201300117A UA104684C2 (ru) | 2010-06-08 | 2011-06-08 | Промежуточное соединение для получения агомелатина (варианты) и способ его получения (варианты) |
Country Status (41)
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012046253A2 (en) * | 2010-10-08 | 2012-04-12 | Msn Laboratories Limited | Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms |
CN102452951B (zh) * | 2010-10-25 | 2014-02-19 | 天津泰普药品科技发展有限公司 | 阿戈美拉汀及其药物组合物 |
ITMI20121444A1 (it) | 2012-08-27 | 2014-02-28 | Procos Spa | Processo per la produzione di agomelatine |
WO2014056421A1 (zh) * | 2012-10-09 | 2014-04-17 | 江西同和药业有限责任公司 | 1-氰基-1-(7-甲氧基-1-萘基)甲醇酯类化合物及其制备方法和应用 |
CN112574066B (zh) * | 2019-09-27 | 2024-10-25 | 江苏豪森药业集团有限公司 | 一种阿戈美拉汀中间体的制备方法 |
WO2021130057A1 (en) * | 2019-12-23 | 2021-07-01 | Dsm Ip Assets B.V. | Dehydrogenation process |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
DE10229842A1 (de) | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
FR2866334B1 (fr) | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine |
FR2866336B1 (fr) * | 2004-02-13 | 2006-03-24 | Servier Lab | Nouveau procede de synthese du (7-methoxy-3,4-dihydro-1-naphtalenyl) acetonitrile et application a la synthese de l'agomelatine |
FR2866335B1 (fr) * | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
WO2007147771A2 (en) * | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
CN101486665B (zh) * | 2009-03-03 | 2013-04-17 | 上海医药工业研究院 | 阿戈美拉汀中间体2-(7-甲氧基-1-萘基)乙酰胺的制备方法 |
EP2705023A4 (en) * | 2011-01-04 | 2014-11-19 | Symed Labs Ltd | PROCESSES FOR THE PREPARATION OF N- [2- (7-METHOXY-1-NAPHTHYLLELYHYL) ACETAMIDE |
-
2010
- 2010-06-08 CN CN2010101973700A patent/CN102276492B/zh not_active Expired - Fee Related
-
2011
- 2011-06-08 EP EP11791930.8A patent/EP2580189B1/en active Active
- 2011-06-08 CA CA2801822A patent/CA2801822C/en not_active Expired - Fee Related
- 2011-06-08 JP JP2013513535A patent/JP5519863B2/ja not_active Expired - Fee Related
- 2011-06-08 ES ES11791930.8T patent/ES2656968T3/es active Active
- 2011-06-08 AP AP2013006659A patent/AP3205A/xx active
- 2011-06-08 MX MX2012013870A patent/MX2012013870A/es active IP Right Grant
- 2011-06-08 LT LTEP11791930.8T patent/LT2580189T/lt unknown
- 2011-06-08 UA UAA201300117A patent/UA104684C2/ru unknown
- 2011-06-08 SI SI201131371T patent/SI2580189T1/en unknown
- 2011-06-08 US US13/702,388 patent/US8779199B2/en active Active
- 2011-06-08 PT PT117919308T patent/PT2580189T/pt unknown
- 2011-06-08 PH PH1/2012/502275A patent/PH12012502275A1/en unknown
- 2011-06-08 MA MA35423A patent/MA34292B1/fr unknown
- 2011-06-08 ME MEP-2018-6A patent/ME02992B/me unknown
- 2011-06-08 SG SG2012085296A patent/SG185667A1/en unknown
- 2011-06-08 WO PCT/CN2011/075438 patent/WO2011153939A1/en active Application Filing
- 2011-06-08 RS RS20171239A patent/RS56659B1/sr unknown
- 2011-06-08 NO NO11791930A patent/NO2580189T3/no unknown
- 2011-06-08 AU AU2011264206A patent/AU2011264206B2/en not_active Ceased
- 2011-06-08 NZ NZ604081A patent/NZ604081A/en not_active IP Right Cessation
- 2011-06-08 BR BR112012031086-0A patent/BR112012031086B1/pt not_active IP Right Cessation
- 2011-06-08 PE PE2012002205A patent/PE20130252A1/es active IP Right Grant
- 2011-06-08 EA EA201201666A patent/EA020271B1/ru unknown
- 2011-06-08 HU HUE11791930A patent/HUE035850T2/en unknown
- 2011-06-08 KR KR1020137000375A patent/KR101470874B1/ko not_active Expired - Fee Related
- 2011-06-08 CU CU20120163A patent/CU24148B1/es active IP Right Grant
- 2011-06-08 DK DK11791930.8T patent/DK2580189T3/da active
- 2011-06-08 PL PL11791930T patent/PL2580189T3/pl unknown
- 2011-06-08 GE GEAP201112941A patent/GEP20156234B/en unknown
- 2011-06-08 MY MYPI2012700965A patent/MY160954A/en unknown
-
2012
- 2012-11-21 TN TNP2012000542A patent/TN2012000542A1/en unknown
- 2012-11-21 ZA ZA2012/08764A patent/ZA201208764B/en unknown
- 2012-11-22 IL IL223180A patent/IL223180A/en active IP Right Grant
- 2012-11-22 CR CR20120592A patent/CR20120592A/es unknown
- 2012-11-30 NI NI201200177A patent/NI201200177A/es unknown
- 2012-11-30 CL CL2012003371A patent/CL2012003371A1/es unknown
- 2012-12-07 EC ECSP12012328 patent/ECSP12012328A/es unknown
- 2012-12-07 GT GT201200328A patent/GT201200328A/es unknown
-
2017
- 2017-11-14 HR HRP20171751TT patent/HRP20171751T1/hr unknown
-
2018
- 2018-01-22 CY CY20181100076T patent/CY1119857T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA104684C2 (ru) | Промежуточное соединение для получения агомелатина (варианты) и способ его получения (варианты) | |
WO2014043706A8 (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
PH12015501258A1 (en) | Methods of synthesizing a prostacyclin analog | |
MX2013011257A (es) | Proceso para la preparacion de dronedarona por n-butilacion. | |
DK2019114T3 (da) | Fremgangsmåde til fremstilling af Drospirenon | |
IN2014DN07599A (ru) | ||
WO2009153206A3 (en) | Improved process for the production of bimatoprost | |
WO2011087316A3 (ko) | 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물 | |
WO2013043009A3 (ko) | 1-팔미토일-3-아세틸글리세롤의 제조방법 및 이를 이용한 1-팔미토일-2-리놀레오일-3-아세틸글리세롤의 제조방법 | |
DK1797021T3 (da) | Fremgangsmåder til fraseparering af modafinil | |
EA201391721A1 (ru) | Способ получения полиморфной формы i эторикоксиба | |
MX2018010128A (es) | Toxina nueva y metodo de preparacion de un intermediario de la misma. | |
JP5918624B2 (ja) | 光学活性含フッ素5,6−ジヒドロピリドン誘導体及びその製造方法 | |
WO2015188243A9 (en) | PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM | |
RU2550510C1 (ru) | Способ получения этил(4е)-5-хлорпент-4-еноата | |
CO6592020A2 (es) | Intemedios de agomelatina y método de preparación de éstos | |
MY147894A (en) | Process for preparing intermediate compound for synthesizing an antiulcerant | |
BR112014029361A2 (pt) | método de produção de ácido tereftálico e seus derivados | |
WO2012116817A3 (en) | Process for producing highly purified n-propanol | |
TH133952A (th) | สารมัธยันตร์อะโกเมลาทีน (Agomelatine intermediate) และ วิธีการเตรียมของสารนั้น | |
CN103880705B (zh) | 二肟基紫罗兰酮及其制备方法和应用 | |
CN105198796B (zh) | 一种合成s‑1‑[(s)‑2‑(3,4,5‑三甲氧苯基)丁酰基]哌啶‑2‑羧酸的方法 | |
CN104774160A (zh) | 一种环丙基甲氰衍生物的制备方法 | |
CN105541797A (zh) | 盐酸巴尼地平的合成工艺 | |
RU2515240C1 (ru) | Способ получения 1-[(2е,4е)-дека-2,4-диеноил]пирролидина |